277 related articles for article (PubMed ID: 22653811)
21. Normal sorting but defective endocytosis of the low density lipoprotein receptor in mice with autosomal recessive hypercholesterolemia.
Jones C; Hammer RE; Li WP; Cohen JC; Hobbs HH; Herz J
J Biol Chem; 2003 Aug; 278(31):29024-30. PubMed ID: 12746448
[TBL] [Abstract][Full Text] [Related]
22. A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes.
Yang J; Wong LY; Tian XY; Wei R; Lai WH; Au KW; Luo Z; Ward C; Ho WI; Ibañez DP; Liu H; Bao X; Qin B; Huang Y; Esteban MA; Tse HF
J Vis Exp; 2018 Sep; (139):. PubMed ID: 30272645
[TBL] [Abstract][Full Text] [Related]
23. A Deep Intronic Variant in LDLR in Familial Hypercholesterolemia.
Reeskamp LF; Hartgers ML; Peter J; Dallinga-Thie GM; Zuurbier L; Defesche JC; Grefhorst A; Hovingh GK
Circ Genom Precis Med; 2018 Dec; 11(12):e002385. PubMed ID: 30562117
[TBL] [Abstract][Full Text] [Related]
24. Pharmacogenetic aspects in familial hypercholesterolemia with the special focus on FHMarburg (FH p.W556R).
Schaefer JR; Kurt B; Sattler A; Klaus G; Soufi M
Clin Res Cardiol Suppl; 2012 Jun; 7(Suppl 1):2-6. PubMed ID: 22528129
[TBL] [Abstract][Full Text] [Related]
25. Serum low density lipoprotein cholesterol level and cholesterol absorption efficiency are influenced by apolipoprotein B and E polymorphism and by the FH-Helsinki mutation of the low density lipoprotein receptor gene in familial hypercholesterolemia.
Gylling H; Aalto-Setälä K; Kontula K; Miettinen TA
Arterioscler Thromb; 1991; 11(5):1368-75. PubMed ID: 1911722
[TBL] [Abstract][Full Text] [Related]
26. Spectrum of low-density lipoprotein receptor (LDLR) mutations in a cohort of Sri Lankan patients with familial hypercholesterolemia - a preliminary report.
Paththinige CS; Rajapakse JRDK; Constantine GR; Sem KP; Singaraja RR; Jayasekara RW; Dissanayake VHW
Lipids Health Dis; 2018 May; 17(1):100. PubMed ID: 29720182
[TBL] [Abstract][Full Text] [Related]
27. Homozygous Familial Hypercholesterolemia Patients With Identical Mutations Variably Express the LDLR (Low-Density Lipoprotein Receptor): Implications for the Efficacy of Evolocumab.
Thedrez A; Blom DJ; Ramin-Mangata S; Blanchard V; Croyal M; Chemello K; Nativel B; Pichelin M; Cariou B; Bourane S; Tang L; Farnier M; Raal FJ; Lambert G
Arterioscler Thromb Vasc Biol; 2018 Mar; 38(3):592-598. PubMed ID: 29284604
[TBL] [Abstract][Full Text] [Related]
28. Low-density lipoprotein apheresis: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2007; 7(5):1-101. PubMed ID: 23074505
[TBL] [Abstract][Full Text] [Related]
29. Heterozygous familial hypercholesterolaemia: the influence of the mutation type of the low-density-lipoprotein receptor gene and PvuII polymorphism of the normal allele on serum lipid levels and response to lovastatin treatment.
Vuorio AF; Ojala JP; Sarna S; Turtola H; Tikkanen MJ; Kontula K
J Intern Med; 1995 Jan; 237(1):43-8. PubMed ID: 7830029
[TBL] [Abstract][Full Text] [Related]
30. The history of Autosomal Recessive Hypercholesterolemia (ARH). From clinical observations to gene identification.
Fellin R; Arca M; Zuliani G; Calandra S; Bertolini S
Gene; 2015 Jan; 555(1):23-32. PubMed ID: 25225128
[TBL] [Abstract][Full Text] [Related]
31. Familial hypercholesterolemia and familial defective apolipoprotein B-100: comparison of the phenotypic expression In 116 cases.
Brugger D; Schuster H; Zöllner N
Eur J Med Res; 1996 May; 1(8):383-6. PubMed ID: 9360938
[TBL] [Abstract][Full Text] [Related]
32. Thyroid hormone regulation and cholesterol metabolism are connected through Sterol Regulatory Element-Binding Protein-2 (SREBP-2).
Shin DJ; Osborne TF
J Biol Chem; 2003 Sep; 278(36):34114-8. PubMed ID: 12829694
[TBL] [Abstract][Full Text] [Related]
33. Clinically used selective oestrogen receptor modulators increase LDL receptor activity in primary human lymphocytes.
Cerrato F; Fernández-Suárez ME; Alonso R; Alonso M; Vázquez C; Pastor O; Mata P; Lasunción MA; Gómez-Coronado D
Br J Pharmacol; 2015 Mar; 172(5):1379-94. PubMed ID: 25395200
[TBL] [Abstract][Full Text] [Related]
34. Influence of LDL receptor gene mutations and the R3500Q mutation of the apoB gene on lipoprotein phenotype of familial hypercholesterolemic patients from a South European population.
Real JT; Chaves FJ; Ejarque I; García-García AB; Valldecabres C; Ascaso JF; Armengod ME; Carmena R
Eur J Hum Genet; 2003 Dec; 11(12):959-65. PubMed ID: 14508510
[TBL] [Abstract][Full Text] [Related]
35. VLDL and IDL apolipoprotein B-100 kinetics in familial hypercholesterolemia due to impaired LDL receptor function or to defective apolipoprotein B-100.
Zulewski H; Ninnis R; Miserez AR; Baumstark MW; Keller U
J Lipid Res; 1998 Feb; 39(2):380-7. PubMed ID: 9507998
[TBL] [Abstract][Full Text] [Related]
36. Genetic and environmental factors affecting the response to statin therapy in patients with molecularly defined familial hypercholesterolaemia.
Miltiadous G; Xenophontos S; Bairaktari E; Ganotakis M; Cariolou M; Elisaf M
Pharmacogenet Genomics; 2005 Apr; 15(4):219-25. PubMed ID: 15864114
[TBL] [Abstract][Full Text] [Related]
37. Impaired adult hippocampal neurogenesis in a mouse model of familial hypercholesterolemia: A role for the LDL receptor and cholesterol metabolism in adult neural precursor cells.
Engel DF; Grzyb AN; de Oliveira J; Pötzsch A; Walker TL; Brocardo PS; Kempermann G; de Bem AF
Mol Metab; 2019 Dec; 30():1-15. PubMed ID: 31767163
[TBL] [Abstract][Full Text] [Related]
38. Intracellular cholesterol accumulation and coenzyme Q
Suárez-Rivero JM; de la Mata M; Pavón AD; Villanueva-Paz M; Povea-Cabello S; Cotán D; Álvarez-Córdoba M; Villalón-García I; Ybot-González P; Salas JJ; Muñiz O; Cordero MD; Sánchez-Alcázar JA
Biochim Biophys Acta Mol Basis Dis; 2018 Dec; 1864(12):3697-3713. PubMed ID: 30292637
[TBL] [Abstract][Full Text] [Related]
39. Phenotypic heterogeneity associated with defective apolipoprotein B-100 and occurrence of the familial hypercholesterolemia phenotype in the absence of an LDL-receptor defect within a Canadian kindred.
Davignon J; Dufour R; Roy M; Bétard C; Ma Y; Ouellette S; Boulet L; Lussier-Cacan S
Eur J Epidemiol; 1992 May; 8 Suppl 1():10-7. PubMed ID: 1505645
[TBL] [Abstract][Full Text] [Related]
40. Heterozygous familial hypercholesterolemia: failure of normal allele to compensate for mutant allele at a regulated genetic locus.
Goldstein JL; Sobhani MK; Faust JR; Brown MS
Cell; 1976 Oct; 9(2):195-203. PubMed ID: 184960
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
